Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of HS-110 in non-small cell lung cancer.

Trial Profile

Phase I study of HS-110 in non-small cell lung cancer.

Phase of Trial: Phase I

Latest Information Update: 26 Apr 2018

At a glance

  • Drugs Viagenpumatucel-L (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Apr 2018 New trial record
    • 18 Apr 2018 According to the Heat Biologics media release, compnay plans to file IND and enroll first patient in this trial in Q4 2018 and anticipates an interim data readout in Q2 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top